Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Osteopontin: an emerging therapeutic target in uraemic vascular disease.

Zhang X, Eirin A, Lerman A, Lerman LO.

Cardiovasc Res. 2013 Jun 1;98(3):332-3. doi: 10.1093/cvr/cvt098. Epub 2013 Apr 23. No abstract available.

2.

Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.

Pedersen TX, Madsen M, Junker N, Christoffersen C, Vikeså J, Bro S, Hultgårdh-Nilsson A, Nielsen LB.

Cardiovasc Res. 2013 Jun 1;98(3):352-9. doi: 10.1093/cvr/cvt049. Epub 2013 Mar 1.

PMID:
23455547
3.

Catch and Release: NG2-Coated Vascular Smooth Muscle Cells Capture Lipoproteins for Macrophages.

Fogelstrand P, Borén J.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):7-8. doi: 10.1161/ATVBAHA.115.306798. No abstract available.

4.

Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.

Byon CH, Han T, Wu J, Hui ST.

Atherosclerosis. 2015 Aug;241(2):313-21. doi: 10.1016/j.atherosclerosis.2015.05.020. Epub 2015 Jun 3.

5.

Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression.

Kim JH, Choi YK, Do JY, Choi YK, Ha CM, Lee SJ, Jeon JH, Lee WK, Choi HS, Park KG, Lee IK.

Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2384-90. doi: 10.1161/ATVBAHA.115.306102. Epub 2015 Sep 24.

6.

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.

Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, Giachelli CM.

Kidney Int. 2012 Dec;82(12):1261-70. doi: 10.1038/ki.2012.322. Epub 2012 Aug 29.

7.

The Plot Thickens Further for Type I Interferons in Atherosclerotic Disease.

de Winther MP.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):217-8. doi: 10.1161/ATVBAHA.115.306907. No abstract available.

8.

Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.

Papadopoulos P, Bousette N, Al-Ramli W, You Z, Behm DJ, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.

Atherosclerosis. 2009 Jun;204(2):395-404. doi: 10.1016/j.atherosclerosis.2008.10.044. Epub 2008 Nov 21.

PMID:
19111831
9.

Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.

Ma L, Zhong J, Zhao Z, Luo Z, Ma S, Sun J, He H, Zhu T, Liu D, Zhu Z, Tepel M.

Cardiovasc Res. 2011 Dec 1;92(3):504-13. doi: 10.1093/cvr/cvr245. Epub 2011 Sep 9.

PMID:
21908651
10.

Fibronectin extradomain A: balancing atherosclerotic plaque burden and stability.

Santovito D, Weber C.

Thromb Haemost. 2015 Jul;114(1):4. doi: 10.1160/TH15-06-0447. Epub 2015 Jun 11. No abstract available.

PMID:
26062571
11.

Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.

Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL.

Arterioscler Thromb Vasc Biol. 2014 May;34(5):1002-10. doi: 10.1161/ATVBAHA.114.303301. Epub 2014 Feb 27.

12.

Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells.

Hu T, Luan R, Zhang H, Lau WB, Wang Q, Zhang Y, Wang HC, Tao L.

Clin Exp Pharmacol Physiol. 2009 Jul;36(7):626-30. doi: 10.1111/j.1440-1681.2008.05124.x. Epub 2008 Nov 28.

PMID:
19076167
13.

Smooth Muscle Hypoxia-Inducible Factor 1α Links Intravascular Pressure and Atherosclerosis--Brief Report.

Liu D, Lei L, Desir M, Huang Y, Cleman J, Jiang W, Fernandez-Hernando C, Di Lorenzo A, Sessa WC, Giordano FJ.

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):442-5. doi: 10.1161/ATVBAHA.115.306861. Epub 2016 Jan 21.

14.
15.

The case against aldosterone: not proven.

Funder JW.

Endocrine. 2012 Dec;42(3):464-5. doi: 10.1007/s12020-012-9749-1. Epub 2012 Jul 21. No abstract available.

PMID:
22820892
16.

Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.

Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1080-6. Epub 2007 Mar 8.

18.

N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.

Wedel J, Hottenrott MC, Bulthuis M, Huitema S, Yard BA, Hillebrands JL.

Transplantation. 2016 Jan;100(1):80-90. doi: 10.1097/TP.0000000000000870.

PMID:
26674731
19.

Increased mTORC1 activity contributes to atherosclerosis in apolipoprotein E knockout mice and in vascular smooth muscle cells.

Ma KL, Liu J, Wang CX, Ni J, Zhang Y, Wu Y, Lv LL, Ruan XZ, Liu BC.

Int J Cardiol. 2013 Oct 15;168(6):5450-3. doi: 10.1016/j.ijcard.2013.03.152. Epub 2013 Aug 23. No abstract available.

20.

Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.

Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):570-5. Epub 2005 Dec 22.

Supplemental Content

Support Center